Advanced Search:
Equity Index

NAVA.OL - NAVAMEDIC

kr33.30  0.2 (0.6%)

Updated: 08:41 May 13, 2024 EST

Next Session's AI Forecast

97.92%

Avg. Accuracy (AI)

kr33.94

Next Week's AI Forecast

0%

Trend's Accuracy (AI)

kr33.77

NAVAMEDIC's Position Within the Medical Distribution Industry
0 (Bottom)
100 (Top) Data Normalization
Rank (0-100)
0 (Bottom)
100 (Top) Data Normalization
Rank (0-100)

NAVAMEDIC - HISTORICAL DATA 6M

  • Last price

    kr33.30

  • Daily change

    kr0.2

  • Previous Close

    kr33.1

  • Last Updated

    08:41 May 13, 2024 EST

CURRENT VOLATILITY

Curr. Week Curr. Month Curr. Quarter Next Quarter Curr Year
-0.61 -0.13 -0.31 -0.1 -0.07

CURRENT VOLATILITY RANK

Variation from the lowest to the highest value in a period.

Curr. Week Curr. Month Curr. Quarter Next Quarter Curr Year
0.61 1.35 1.86 1.63 1.73

STOCHASTIC METRIC

The STOCHASTIC METRIC shows when a financial asset has moved into an overbought or oversold position.

OVERSOLD
OVERBOUGHT
Curr. Week Next Week Curr. Month Curr. Quarter
0% 50% 38.89% 9.72%

MOVING AVERAGE METRIC

5 Sessions Change 5 Sessions 20 Sessions Change 20 Sessions 50 Sessions Change 50 Sessions 200 Sessions
33.1 -0.87% 33.39 -2.48% 34.24 -6.65% 36.68

RSI METRIC

RS Hour RSI Hour RS Day RSI Day
0.73 25.93 0.88 42.2

NAVAMEDIC Technical Analysis News

NAVAMEDIC

Henrik Ibsensgate 100
Oslo 0255
Norway
47 67 11 25 40
https://www.navamedic.com

Sectors: Healthcare
Industry: Medical Distribution
F. Time Employees: 45
Description

Navamedic ASA, a pharmaceutical company, develops, produces, markets, and sells pharmaceuticals and related products in Northern Europe. The company's product portfolio includes prescription and non-prescription pharmaceuticals, as well as medical nutrition products, medical devices, food supplements, and cosmetics. It offers medical nutrition products for various therapeutic areas, including phenylketonuria, homocystinuria, maple syrup urine disease, tyrosinemia, methylmalonic acidemia/propionic acidemia, glutaric aciduria, isovaleric acidemia, and urea cycle disorders, as well as products for glycogen storage diseases and renal diseases, fat metabolism, malnutrition, and ketogenic diet. In addition, the company provides consumer health products consisting of non-prescription drugs and health care products for pain relief, cough and cold, gastro, obesity, women's health, and others primarily through pharmacies and drugstores; specialty pharmaceutical products in various therapeutic areas comprising dermatology, wound care, urology, and obesity; and branded generics, including cardiology products and antibiotics. It sells, markets, and distributes its products to hospitals, patients, and pharmacies. The company was formerly known as Glucomed AS and changed its name to Navamedic ASA in 2004. Navamedic ASA was incorporated in 2002 and is headquartered in Oslo, Norway.

Corporate Governance

Navamedic ASA’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.